These data indicate a probiotic–gut microbiota–butyrate–GLP-1 axis that improves metabolic function and protects against high-fat diet-induced obesity and diabetes without using GLP-1 agonists and their side effects [76]. The gene discussed is GCG; the disease is diabetes mellitus.